Patient-reported outcomes (PROs) in chronic urticaria

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Patient-reported outcomes (PROs) in chronic urticaria. / Moestrup, Kristian; Ghazanfar, Misbah N.; Thomsen, Simon F.

I: International Journal of Dermatology, Bind 56, Nr. 12, 12.2017, s. 1342-1348.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Moestrup, K, Ghazanfar, MN & Thomsen, SF 2017, 'Patient-reported outcomes (PROs) in chronic urticaria', International Journal of Dermatology, bind 56, nr. 12, s. 1342-1348. https://doi.org/10.1111/ijd.13668

APA

Moestrup, K., Ghazanfar, M. N., & Thomsen, S. F. (2017). Patient-reported outcomes (PROs) in chronic urticaria. International Journal of Dermatology, 56(12), 1342-1348. https://doi.org/10.1111/ijd.13668

Vancouver

Moestrup K, Ghazanfar MN, Thomsen SF. Patient-reported outcomes (PROs) in chronic urticaria. International Journal of Dermatology. 2017 dec;56(12):1342-1348. https://doi.org/10.1111/ijd.13668

Author

Moestrup, Kristian ; Ghazanfar, Misbah N. ; Thomsen, Simon F. / Patient-reported outcomes (PROs) in chronic urticaria. I: International Journal of Dermatology. 2017 ; Bind 56, Nr. 12. s. 1342-1348.

Bibtex

@article{e2bbbd21276d40de98721c1068b591f8,
title = "Patient-reported outcomes (PROs) in chronic urticaria",
abstract = "Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.",
author = "Kristian Moestrup and Ghazanfar, {Misbah N.} and Thomsen, {Simon F.}",
year = "2017",
month = dec,
doi = "10.1111/ijd.13668",
language = "English",
volume = "56",
pages = "1342--1348",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "12",

}

RIS

TY - JOUR

T1 - Patient-reported outcomes (PROs) in chronic urticaria

AU - Moestrup, Kristian

AU - Ghazanfar, Misbah N.

AU - Thomsen, Simon F.

PY - 2017/12

Y1 - 2017/12

N2 - Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.

AB - Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.

U2 - 10.1111/ijd.13668

DO - 10.1111/ijd.13668

M3 - Review

C2 - 28567776

AN - SCOPUS:85020081171

VL - 56

SP - 1342

EP - 1348

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 12

ER -

ID: 196716158